New cancer therapies in 2022 achieving unprecedented remissions - reviewing a year of hope
Including gene editing, immunotherapy, modified viruses, vaccines, personalised medicine, and nanotechnology
Join the club for FREE to access the whole archive and other member benefits.
NHS Foundation Trust in Manchester
The Christie NHS Foundation Trust is one of Europe’s leading cancer centres, treating over 60,000 patients a year. It is based in Manchester and serve a population of 3.2 million across Greater Manchester and Cheshire, but as a national specialist around 15% patients are referred to us from other parts of the country.
The Christie provide radiotherapy through one of the largest radiotherapy departments in the world; chemotherapy on site and through 14 other hospitals; highly specialist surgery for complex and rare cancer; and a wide range of support and diagnostic services.
An international leader in research. Most of the cancer research in Manchester is undertaken on the Christie site, has been officially ranked the best in the UK.
Visit website: https://www.christie.nhs.uk/
the-christie-nhs-foundation-trust
See also: NHS - UK National Health Service, publicly funded healthcare system in England
Details last updated 01-Feb-2022
Clinical Senior Lecturer in Experimental Cancer Medicine and Honorary Consultant in Medical Oncology
Including gene editing, immunotherapy, modified viruses, vaccines, personalised medicine, and nanotechnology
New tech at NHS trusts speeds up cancer detection in high-risk areas
Greater convenience for patients and could potentially reduce NHS costs
A 51-year-old patient in trial is now cancer-free with immunotherapy drug and chemotherapy
Experimental gene therapy shrunk tumor size by 50% within three months
Identifying faulty genes and matching cancer patients to potential experimential therapies